China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Aumolertinib plus Radiotherapy versus Aumolertinib Monotherapy in Patients with Stage IV Lung Adenocarcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130994
Registration Time: 2026/08/27
Type: Observational study
Primary Sponsor: Shandong Provincial Hospital (Shandong Children's Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336406
Published by HT Digital Content Services with permission from Health Daily Digest....